Neutralization of cytomegalovirus virions: The role of complement

Journal of Infectious Diseases

Volumn 176, Issue 2, 1997, Pages 339-347

  Brad Spiller, O ^b   Melanie Hanna, S ^b   Devine, Dana V ^a   Tufaro, Frank ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY COMBINING SITE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; COMPLEMENT ACTIVATION; CYTOLYSIS; CYTOMEGALOVIRUS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCOMPETENCE; PRIORITY JOURNAL; VIRION; VIRUS INFECTION; VIRUS NEUTRALIZATION;

EID: 16944363307     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514050     Document Type: Article

References (14)

1. Morgan BP. Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem J 1989;264:1-14.
2. Cooper NR, Welsh RM Jr. Antibody- and complement-dependent viral neutralization. Springer Semin Immunopathol 1979;2:285-310.
3. Sissons JGP, Oldstone MBA. Antibody-mediated destruction of virus-infected cells. Adv Immunol 1980;29:209-60.
4. Hirsch RL. The complement system: its importance in the host response to viral infection. Microbiol Rev 1982;46:71-85.
5. Quinnan GV, Kirmani N, Rook AH, et al. Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-Iymphocyte cytotoxic responses correlate with recovery from CMV in bone marrow-transplant recipients. N Engl J Med 1982;307:7-13.
6. Rook AH, Quinnan GV, Fredrick WJR, et al. Importance of cytotoxic lymphocytes during CMV infection in renal transplant recipients. Am J Med 1984;76:385-92.
7. Reusser P, Riddell SR, Meyers JD, Greenberg PD. Cytotoxic T-lymphocyte response to CMV after human allogeneic bone marrow transplantation: pattern of recovery and correlation with CMV infection and disease. Blood 1991;78:1373-80.
8. Cheng-Rong L, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR. Recovery of HLA-restricted CMV-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994;83:1971-9.
9. Lopez C, Simmons RL, Mauer SM, Najarian JS, Good RA. Association of renal allograft rejection with virus infection. Am J Med 1974;56: 280-9.
10. Lonnqvist B, Ringden O, Wahren B, Gahrton G, Lundgren G. HCMV infection associated with and preceding chronic grafl-versus-host disease. Transplantation 1984;38:465-8.
11. Rinaldo CR, Carncy WP, Richter BS, Black PH, Hirsch M. Mechanisms of immunosuppression in cytomegalovirus mononucleosis. J Infect Dis 1980;141:488-95.
12. Weber B, Braun W, Cinatl J, Doerr HW. Humoral response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens. J Clin Invest 1993;71:270-6.
13. Hayes K, Alford C, Britt W. Antibody response to virus-encoded proteins after cytomegalovirus mononucleosis. J Infect Dis 1987;156:615-21.
14. Britt WJ. Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus. Virol 1984; 135:369-78.